Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Rxo (RXO) Shares Outstanding (2022 - 2025)

Rxo's Shares Outstanding history spans 4 years, with the latest figure at $164.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 1.01% year-over-year to $164.2 million; the TTM value through Dec 2025 reached $164.2 million, up 1.01%, while the annual FY2025 figure was $164.2 million, 1.01% up from the prior year.
  • Shares Outstanding reached $164.2 million in Q4 2025 per RXO's latest filing, roughly flat from $164.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $164.2 million in Q4 2025 to a low of $116.4 million in Q4 2022.
  • Average Shares Outstanding over 4 years is $138.4 million, with a median of $117.6 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: increased 0.54% in 2023, then skyrocketed 39.45% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $116.4 million in 2022, then increased by 0.54% to $117.0 million in 2023, then soared by 38.87% to $162.5 million in 2024, then increased by 1.01% to $164.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Shares Outstanding are $164.2 million (Q4 2025), $164.1 million (Q3 2025), and $164.0 million (Q2 2025).